Life Technologies and DaAn Gene Form Joint Diagnostic Business

Financial terms of the deal were not disclosed.

Life Technologies DaAn Diagnostics will develop and commercialize a portfolio of molecular diagnostic assays using Life Technologies' 3500Dx capillary electrophoresis instrument and the Big Dye Cycle Sequencing technologies, focused on IVD assays for oncology, infectious, and genetic diseases. The joint venture allows both companies to expand the use of capillary electrophoresis technology into the Chinese clinical diagnostics market.

The 3500Dx instrument is a capillary-based Sanger Sequencer intended for use in the analysis of human DNA for the detection of genetic changes that indicate disease presence or improved response to various therapies. The genetic analyzer was approved by China's State Food and Drug Administration (SFDA) for IVD diagnostic use in China in October 2011.

"The joint venture will help us offer leading medical diagnostic technologies with cost-effective solutions to Chinese healthcare professionals," said Dr. Siddhartha Kadia, president of Life Technologies, Greater China. "This approach leverages our expertise in platform development and DaAn's expertise in regulated markets with kit development and commercialization."

DaAn Gene Co., Ltd. of Sun Yat-sen University (Guangzhou, China) is a biotech enterprise focused on molecular diagnostic techniques. With the Certificate of Good manufacturing practice (GMP), DAAN Gene is committed to R&D, production, and service of in vitro diagnostic products.

Life Technologies is a global biotechnology company whose systems, consumables, and services enable scientists to accelerate scientific and medical advancements to improve human health. The company manufactures both molecular diagnostic and research use only products.

Related Links:
Life Technologies
DaAn Gene
Sun Yat-sen University